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Human osteosarcoma MG-63 cells were induced into differentiation by 5 mmol/L 
hexamethylene bisacetamide (HMBA). Their nuclear matrix proteins (NMPs) were 
selectively extracted and subjected to two-dimensional gel electrophoresis analysis. 
The results of protein patterns were analyzed by Melanie software. The spots of 
differentially expressed NMPs were excised and subjected to in situ digestion with 
trypsin. The maps of peptide mass fingerprinting were obtained by MALDI-TOF- 
MS analysis, and were submitted for NCBI database searches by Mascot tool. 
There were twelve spots changed remarkably during the differentiation induced 
by HMBA, nine of which were identified. The roles of the regulated proteins 
during the MG-63 differentiation were analyzed. This study suggests that the 
induced differentiation of cancer cells is accompanied by the changes of NMIPs, and 
confirms the presence of some specific NMPs related to the cancer cell proliferation 
and differentiation. The changed NMPs are potential markers for cancer diagnosis 
or targets for cancer therapy. 
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Introduction 
Nuclear matrix (nuclear skeleton) is the filamentous 
protein framework in eukaryotic cell nucleus. It plays 
an important role in life activities, such as cell mor- 
phology maintaining, dimensional localization, DNA 
replication and transcription; thereby it is closely as- 
sociated with cell proliferation and differentiation, as 
well as carcinogenesis ( 1 , 2 ) .  
The role of nuclear matrix in cell activities has 
drawn increasingly attentions recently. Most of its 
components, besides the fibrins, are proteins and/or 
enzymes in DNA replication, transcription, and gene 
expression (3-5).  The nuclear matrix in cancer cells is 
not only abnormal in morphology but also apparently 
different in its composition. 
Previously, we have found that the morphology of 
nuclear matrix in human gastric cancer cells showed 
similar characteristics to  that in normal cells when in- 
duced by hexamethylene bisacetamide (HMBA) and 
retinoic acid (RA) ( 6 ,  7). It implies that further study 
on the differential expression of nuclear matrix pro- 
teins (NMPs) in response to differentiation reagents 
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will be able to reveal the mechanism of carcinogenesis 
and cancer differentiation. 
This study was designed to identify specific NMPs 
associated with the proliferation and differentiation 
of carcinoma cells for further analysis. The human 
osteosarcoma MG-63 cells, which have apparent char- 
acteristics of terminal differentiation, were selected 
to undergo the terminal differentiation induced by 
HMBA. When the differentiation of IVIG-63 cells was 
confirmed, their NMPs were selectively extracted and 
subjected to two-dimensional (2D) gel electrophore- 
sis. The changed NMPs during the differentiation 
process were identified by matrix-assisted laser des- 
orption/ionization time-of-flight mass spectrometry 
(MALDI-TOF-MS) analysis combineld with database 
mining. 
Results 
Changes of NMPs 
The human osteosarcoma MG-63 cells were cultured 
in the presence or absence of HMBA for seven days. 
Samples of NMPs were selectivlely ext,racted and sub- 
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jected to 2D gel electrophoresis. The criteria for 
differentially expressed proteins were based on an 
evaluation of at least two gels per experimental con- 
dition. Most of the NMPs were concentrated in the 
area of p l  4-7 with molecular weight (MW) 10-70 
kDa. There were 199 spots in the map of NMPs from 
control MG-63 cells, whereas there were 197 spots in 
that from HMBA-treated MG-63 cells. The expres- 
sion of 12 spots was changed remarkably by the addi- 
tion of HMBA. The changed proteins were named as 
special NMPs (SNMPs or S). Among them, six spots 
(Sl-S6) were up-regulated, four (S7-S10) were down- 
regulated, while the remaining two (S11 and S12) were 
emerged as new spots in the nuclear matrix maps of 
the differentiated MG-63 cells (Figures 1-3). The rel- 
ative expression levels of the altered proteins were an- 
alyzed in the differentiated and control cells (Figure 
4). 
Peptide mass spectra of the changed 
proteins 
In the twelve changed proteins, ten proteins (Sl- 
S7 and S10-S12) obtained ideal peptide mass 
fingerprinting maps. The representative mass spec- 
tra (S6, S7, and S12) are shown in Figure 5. 
Identification of the changed proteins 
Nine differentially expressed proteins (Sl-S4, S6, 
S7, S10-S12) were identified by peptide mass 
fingerprinting combined with database searching. 
The identified proteins and their associated param- 
eters are shown in Table 1. Among the identified 
proteins, S1 was the major histocompatibility com- 
plex (MHC) class I1 antigen; S2 was the interferon- 
stimulated gene factor 3 alpha 91/84 kDa protein, 
which is associated with the activation of interferon- 
stimulated genes; S3 was the hypothetical protein 
DKFZp434M2221.1, an unknown function protein; S4 
was the 8-hydroxy-guanine glycosylase homolog oggl, 
an enzyme in nucleotide metabolism; S6 and S10 were 
identified as vimentin and actin, respectively, both 
are common NMPs; S7 was the hnRNP A2/B1, which 
is associated with mRNA biogenesis; S11 was similar 
to the 60s ribosomal protein L21; and S12 was iden- 
tified as the ST2 protein, a member of the interleukin 
receptor I family. In addition, S5 was matched with 
two proteins, which needs further identification. 
Discussion 
Differentiation therapy is a novel and potentially less 
toxic form of cancer treatment involving the use of 
reagents that modify the differentiation and growth of 
cancer cells (8, 9). Information on the differentiation 
of carcinoma cells had been very limited until recently. 
It was reported that the polymorphism of nuclear ma- 
trix changed remarkably in differentiated gastric car- 
cinoma cells (6, 7 )  ,while changes of NMPs were unex- 
plored. It is of significance to identify specific NMPs 
associated with cell proliferation and differentiation, 
as the identified NMPs are potentially markers for the 
differentiation of carcinoma cells or targets for cancer 
therapy. 
HMBA is one of the most commonly used 
differentiation-inducing reagents (10). It is re- 
ported that HMBA can induce various cancer cells 
into differentiation. In this study, the human os- 
teosarcoma MG-63 cells were induced by HMBA 
as a differentiation model. Characteristics of 
differentiated MG-63 cells were identified in previous 
studies (11) .  In brief, divisions of the MG-63 cells 
were largely inhibited, and the ratio of cells in the 
Go/G1 phase increased remarkably after being treated 
with HMBA. The proteins specific for osteoblast cells, 
such as collagen I, osteonectin, and osteocalcin, in- 
creased in HMBA-treated MG-63 cells. It was de- 
duced that MG-63 cells in the presence of HMBA were 
induced into differentiation as it showed characteris- 
tics of the osteoblast cells. 
In our experiments, twelve spots changed remark- 
ably on the 2D maps of NMPs from differentiated 
MG-63 cells, and nine spots were identified. Ac- 
cording to their expression levels in MG-63 cells, the 
nine proteins were divided into three classes: (1) up- 
regulated proteins: Sl-S4, S6; (2) down-regulated 
proteins: S7 and S10; (3) newly emerged proteins: 
S11 and S12. Among them, six proteins, including 
S1, S6, S7, S10-S12, were reported to  be closely asso- 
ciated with cell growth and differentiation (12-16). 
Changes of vimentin and actin are common in the 
differentiated carcinoma cells (15). In this study, vi- 
mentin increased while actin decreased in the differen- 
tiated MG-63 cells. In the human hepatocellular car- 
cinoma Hep 3B cells, TPA can induce the increased 
expression of both vimentin and actin, while RA can 
increase the expression of actin and decrease that of 
vimentin. The roles that vimentin and actin play in 
cell differentiation and their effects on the polymorph- 
ism of differentiated cells currently remain unknown. 
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Fig. 1 The 2D maps of NMPs from MG-63 cells (stained with coomassie blue R250). A. Control; B. MG-63 cells 
treated with HMBA. Arrows point to differentially expressed proteins. Sl-S6: up-regulated; S10: down-regulated; S11 
and S12: newly emerged proteins. 
A B 
Fig. 2 The 2D maps of NMPs from MG-63 cells (alkaline terminal, p 1  8-10, stained with coomassie blue R250). A. 
Control; B. MG-63 cells treated with HMBA. Arrows point to differentially expressed proteins. S7-S9: down-regulated. 
Fig. 3 Enlarged maps of the changed NMPs. Arrows point to the changed NMPs. 
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Fig. 4 Relative expression levels of the changed NMPs. The expression levels of Sl-S6 increased, whereas those of 
S7-S10 decreased in the NMPs from HMBA-treated MG-63 cells; the expression levels of S11 and S12 were close to 
the background in the control cells. 
Table 1 Nuclear Matrix Proteins Regulated in Differentiated MG-63 Cells Identified by Peptide 
Mass Fingerprinting 
Class Protein Accession Name M r l p I  Matched Sequence 
No. peptide coverage 
Up-regulated S1 gi12944406 MHC class I1 antigen 10,99515.14 3* 34% 
S2 gi 1252585 interferon-stimulated 11,76315.19 4 40% 
gene factor 3 alpha 
91/84 kDa pro- 





S3 gil7512660 hypothetical protein 25,91118.72 5 28% 
S4 gi( 11281913 8-hydroxy-guanine 39,47218.75 7 24% 
S5# gi127544933 solute carrier family 36,542/9.87 7 35% 
25, member 16 
ing protein 19 
gi129126189 Rho GTPase activat- 35,94919.90 8 24% 
S6 nil2119204 vimentin 53,67615.06 12 29% 
Down-regulated S7 gi(4504447 hnRNP A2 36,04118.67 8 37% 
gill4043072 hnRNP B1 37,46418.97 8 35% 
- - - - S8# - 
~ - - - s9# - 
S10 gill5277503 actin 40,53615.55 11 35% 
Newly emerged S11 gi141147370 similar to 60s riboso- 11,324110.14 5 59% 
S12 gi1423090 ST2 protein 37,65518.21 4 21% 
ma1 protein L21 
*S1: matched peptides below 4; #S5, S8, S9: unidentified proteins. S5 was matched with two proteins, which needs 
further identification. 
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Fig. 5 The MALDI-TOF-MS maps of S6, S7, and S12. 
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It is of significance to make clear the roles that vi- 
mentin and actin play in the polymorphism and or- 
ganization of nuclei during the differentiation of car- 
cinoma cells, since they are commonly expressed in 
eukaryotic cells. 
The hnRNP A2/B1 is involved in various steps of 
mRNA biogenesis and transgort . The overexpression 
of hnRNP A2/B1 was found in various carcinoma cells 
( 1 6 ) ,  so hnRNP A2/B1 was believed to  play an impor- 
tant role in carcinogenesis and cell differentiation. In 
this study, the expression of hnRNP A2/B1 decreased 
remarkably in the nuclear matrix of differentiated 
MG-63 cells, gaving further evidence that hnRNP 
A2/B1 was involved in the differentiation of carci- 
noma cells. 
The 8-hydroxy-guanine glycosylase homolog oggl 
is responsible for repairing the 8-hydroxyguanine 
(oh'G), a major base lesion produced by reactive oxy- 
gen species, thus repairs the mutations that lead to 
carcinogensis ( 1  7). The expression of oggl increased 
in the differentiated MG-63 cells, implying that DNA 
repair enzymes are involved in the HMBA-induced 
differentiation process. 
The results of this study confirm that specific 
NMPs are related to the proliferation and 
differentiation of carcinoma cells. Further study on 
the functions of the changed proteins on the human 
osteosarcoma cell carcinogenesis and differentiation, 
as well as their relationship with activities of as- 
sociated oncogenes and tumor-suppressor genes, is 
important as it could not only reveal the regulation 
mechanism on cell proliferation and differentiation, 
but also shed light on the principle of carcinogenesis 
and its regression. On the other hand, it will pro- 
vide novel markers of carcinoma cell differentiation 
for clinical diagnosis and/or novel targets for cancer 
therapy. 
Materials and Methods 
Materials 
The human osteosarcoma MG-63 cells were bought 
from the China Center for Type Culture Collection 
(Wuhan, China). HMBA (Sigma, St. Louis, USA) 
was used to induce the differentiation of MG-63 cells. 
Sequence grade, modified trypsin (Promega, Madi- 
son, USA), and iodoacetamide (Sigma) were used in 
the in-gel digestion. ReadyStrip IPG strips (pH 3-10, 
11 cm) and IPG buffer (pH 3-10) were bought from 
Amersham Biosciences (Pittsburgh, USA). Other 
reagents used in 2D gel electrophoresis and the 
coomassie blue R250 were bought from Shanghai San- 
gon Biological Engineering Technology and Service 
Co., Ltd., China. 
Cell culture 
The MG-63 cells were cultured in the RPMI-1640 
medium supplemented with 15% newly-born bovine 
serum, 100 ku/L penicillin, and 100 mg/L strepto- 
mycin at 37°C. The cells were seeded in a constant 
density overnight, and then treated with 5 mmol/L 
HMBA for 7 days. Eesh culture media were added 
to the cells every 48 h. The cells were harvested at 
subconfluency and stored at -80°C. 
Purification of NMPs 
NMPs were extracted by a method of Michishita et 
a1 ( 1 8 ) .  MG-63 cells were washed-with PBS and 
extracted with a cytoskeleton buffer CSKlOO (10 
mmol/L PIPES pH 6.8, 300 mmol/L sucrose, 100 
mmol/L NaCl, 4 mmol/L MgC12, 1.0 mmol/L PMSF, 
and 0.5% Triton X-100) at 0°C for 10 min. After be- 
ing sheered through a 16-gauge needle, the nuclei were 
subjected to  centrifugation for 5 min at 400 g. The 
deposition was washed twice with CSK50 (10 mmol/L 
PIPES pH6.8, 300 mmol/L sucrose, 50 mmol/L NaC1, 
4 mmol/L MgC12, 1.0 mmol/L PMSF, and 0.5% Tri- 
ton X-loo), then digested for 30 min at 25°C in the 
same buffer containing 500 u/mL DNase I. A con- 
centration of 1 mol/L ammonium sulfate was added 
dropwise to a final concentration of 0.25 mol/L. Af- 
ter incubation for 15 min, the NMPs were pelleted by 
centrifugation at 1,000 g for 5 min, and washed once 
with the CSK50 buffer, then stored at -80°C. In ad- 
dition, the protein concentrations were determined by 
the Bradford method. 
2D gel electrophoresis 
To solubilize nuclear proteins, the pellets of NMPs 
were resuspended in a 2D buffer containing 7 mol/L 
urea, 2 mol/L thiourea, 4% CHAPS, and 50 mmol/L 
DTT, then were ultrasonicated for 2 min. The su- 
pernatant was centrifuged for 30 min at  16,000 g at 
4°C. Typically 200 pg protein was loaded. IEF was 
performed in 1 2 ~ 0 . 2  cm acrylamide rods or ReadyS- 
trip IPG strips, respectively. The acrylamide rods 
contained 4% acrylamide, 9.5 mol/L urea, 2.0% NP- 
40, and 0.5% carrier ampholytes of pH 3-10. The 
rods were subjected to a three-step pre-electrophoresis 
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with 15 min at 200 V, 30 min at 300 V, and 1 h at 400 
V. Focusing was performed for a total of 11,000 V.h. 
ReadyStrip IPG strips were rehydrated overnight in a 
reswelling tray with rehydration buffer. IEF was car- 
ried out on a Protean IEF Cell (Bio-Rad, Hercules, 
USA) at 19°C with a maximum current setting of 
80 pA/strip. Focusing was performed for a total of 
70,000 V.h. Before carrying out the 2D SDS-PAGE, 
the strips were equilibrated in an equilibration buffer 
consisting of 10% glycerol, 2% SDS, 60 mmol/L Tris- 
HC1 of pH 6.8, and 5% mercaptoethanol for 20 min at 
room temperature. The strips were then transferred 
onto the 1-mm-thick 2D SDS-PAGE gel and sealed 
in place with 1% agarose. The 2D SDS-PAGE was 
performed on a 12.5% acrylamide/bisacrylamide gel 
at 50 V for 30 min followed by 170 V for 8 h. The gel 
was run in the following electrode buffer: 25 mmol/L 
Tris, 192 mmol/L glycin, and 0.1% SDS. The 2D SDS- 
PAGE standards were used for gel calibration. The 
gel was stained with 0.25% coomassie blue R250 and 
destained with 5% methanol and 7.5% acetic acid. 
The 2D maps of NMPs were subjected and analyzed 
by Melanie software. Protein spots were manually ex- 
cised for MS analysis. 
Protein identification by MALDI-TOF- 
MS analysis 
In-gel protein digestion 
Spots were cut into about 1 mm3 pieces, washed twice 
with 80 pL of 25 mmol/L NH4HC03 and 50% acetoni- 
trile for 5 min, then dehydrated with 80 pL of acetoni- 
trile. Reduction was achieved by 1 h treatment with 
10 mmol/L DTT in 100 mmol/L NH4HC03 at 57°C. 
Alkylation was performed with 25 mmol/L iodoac- 
etamide/100 mmol/L NH4HC03 for 45 min at 25°C. 
Finally, gel spots were washed 3 times for 5 min alter- 
natively with 100 mmol/L ammonium carbonate and 
acetonitrile. Gel pieces were completely dried with 
a Speed Vac before trypsin digestion. Appropriate 
volumes of trypsin (12.5 mg/L, freshly diluted in 50 
mmol/L NH4HC03) were added to the dried gel. The 
digestion was performed at 37°C overnight. After cen- 
trifuged for 5 min in a Speed Vac, the gel pieces were 
incubated in 10 pL of 20 mmol/L NH4HC03 for 20 
min at room temperature, and then incubated in 10 
pL of 5% TFA/50% acetonitrile for 5 min at room 
temperature. The mixture was centrifuged at 6,000 g 
for 5 min. The supernatant was mixed and then com- 
pletely dried with a Speed Vac. 
MALDI-TOF-MS analysis 
For MALDI-TOF-MS analysis, samples were resolved 
in 2 pL of 0.1% TFA separately. Mass measure- 
ments were carried out on a Brucke:r ULTRAFLEX 
TOF/TOF mass spectrometer (Brernen, Germany). 
This instrument was used at a maximum accelerat- 
ing potential of 20 kV (in positive mode) and was 
operated in reflector mode. A total of 0.5 pL sat- 
urated solution of the a-cyano-Chydroxy cinnamic 
acid in 0.1% TFA/30% acetonitrile was mixed with 
0.5 pL sample solution, and added to the target. 
In positive mode, internal calibration was performed 
with tryptic peptides coming from autodigestion of 
trypsin (monoisotopic masses at m / z  842.51 and m / z  
2211.10). Monoisotopic peptide masses were assigned 
and used for database searching. The data were 
searched against an NCBI non-redundant protein se- 
quence database using the Mascot tool from Matrix 
Science. All proteins presented in the NCBI database 
were taken into account without any PI or Mr  re- 
strictions. One possible missed cleavage for trypsin 
digestion was selected; the fix modification was car- 
bamidomethyl (C) and the variable modification was 
oxidation (M) . 
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